已发表论文

鼻窦鳞状细胞癌患者术前中性粒细胞与淋巴细胞比率的预后价值

 

Authors Zhong B, Deng D, Du JT, Chen F, Liu YF, Liu SX

Received 15 September 2019

Accepted for publication 10 November 2019

Published 15 November 2019 Volume 2019:11 Pages 9733—9741

DOI https://doi.org/10.2147/CMAR.S231085

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Ms Sandhya Gopi

Peer reviewer comments 2

Editor who approved publication: Dr Sanjeev Srivastava

Objective: This study explored the effectiveness of a new inflammatory prognostic system, using preoperative neutrophil to lymphocyte ratio (NLR) to predict the postoperative survival rate of patients with sinonasal squamous cell carcinoma (SSCC).
Methods: Patients diagnosed with SSCC who undergone surgically treated without neoadjuvant therapy were included in the study between May 2008 and October 2017. Preoperative NLR is defined as: preoperative neutrophil/postoperative lymphocyte ratio. The prognostic value was uncovered by univariate and multivariate Cox hazards analysis.
Results: A total of 147 patients were included in this study. Through the multivariate analysis, pathological T stage (hazard ratio [HR] 1.719, confidence interval [CI] 1.277–3.642, p<0.001), pathological N stage (HR 1.344, 95% CI 1.015–2.776, p<0.001), and preoperative NLR (HR 1.579, 95% CI 1.217–3.092, p=0.002) were independent risk factor for overall survival (OS). Pathological T stage (HR 1.835, 95% CI 1.141–3.132, <0.001), pathological N stage (HR 1.281, 95% CI 1.169–2.476, p<0.001), and preoperative NLR (HR 1.688, 95% CI 1.162–3.363, p p<0.001) were also independently associated with disease-free survival (DFS). Pathological T stage (HR p<0.001, 95% CI 1.537–3.021, p<0.001), pathological N stage (HR1.571, 95% CI 1.157–2.258, p<0.001), and preoperative NLR (HR 1.509, 95% CI 1.153–3.104, p=0.001) were independent risk factors for disease-specific survival (DSS).
Conclusion: The preoperative NLR is considered to be a useful predictor of postoperative survival in SSCC patients.
Keywords: sinonasal carcinoma, albumin-to-globulin ratio, patients, risk factor, survival




Figure 1 OS (A), DSS (B) and...